Annual report pursuant to Section 13 and 15(d)

Statements of Operations

v3.19.3.a.u2
Statements of Operations - USD ($)
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Operating expenses:    
Research and development $ 12,120,318 $ 5,971,833
General and administrative 3,757,251 4,022,307
Total operating expenses 15,877,569 9,994,140
Loss from operations (15,877,569) (9,994,140)
Other income (expense):    
Interest income 320,011 86,527
Interest expense (7,300) (5,786)
Local business tax (1,601) (1,188)
Other income 456 446
Total other income (expense), net 311,566 79,999
Loss before income taxes (15,566,003) (9,914,141)
Income tax benefit
Net loss (15,566,003) (9,914,141)
Deemed dividend of Series D preferred stock (1,412,041)
Net loss applicable to common shareholders $ (15,566,003) $ (11,326,182)
Basic and diluted net loss per share $ (0.37) $ (0.87)
Shares used to compute basic and diluted net loss per share 42,283,947 13,039,123